Evonik Industries Reportedly Rejects BASF's Acquisition Offer
Evonik Industries AG (EVKIF.PK) rejected a 10.3 billion euro acquisition offer from BASF SE (BAS.DE) as it was deemed too low. BASF offered 22.15 euros per share, valuing Evonik at 14.2 billion euros. Evonik's market cap is 8.4 billion euros, and its enterprise value is around 12 billion euros. Combined revenues of both companies were 74 billion euros last year. Evonik's shares were down 1.28 percent on the Frankfurt Exchange.
How this was made
The 30-second read
Why it matters
The immediate share price decline for Evonik reflects disappointment, while BASF may need to reassess its growth strategy.
Market read
First disclosure of a major M&A bid in the European chemicals sector, with immediate price impact on both parties.
What to watch
Regulatory scrutiny in Europe and potential antitrust concerns may have influenced Evonik's decision.
Background
BASF, the world's largest chemical producer, attempted a €10.3 bn takeover of Evonik, a leading specialty chemicals firm. The offer was deemed insufficient by Evonik's board.
Ticker impact
Evonik rejected BASF's €10.3 bn acquisition offer, causing its shares to fall 1.28% on the Frankfurt exchange.
likely pressure as investors price in the missed premium and uncertainty over future M&A options
The offer was publicly disclosed for the first time and was deemed too low, prompting an immediate share decline.
Market effects
The chemicals sector may see heightened scrutiny of M&A activity and valuation multiples.
European markets could experience modest volatility as the deal collapse influences peer valuations.
Limited to chemicals and industrials; no broad market impact.
Counterpoint
The rejection could be a catalyst for Evonik to pursue alternative strategic partners, potentially unlocking higher value later.
Key entities
- CompanyEvonik Industries AG
German specialty chemicals group that rejected the acquisition offer.
- CompanyBASF SE
German chemicals giant that made the €10.3 bn bid.
